Article info

Protocol
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK

Authors

  1. Correspondence to Professor Timothy Simon Walsh; twalsh{at}staffmail.ed.ac.uk
View Full Text

Citation

Walsh TS, Aitken LM, McKenzie CA, et al
Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness randomised trial in the UK

Publication history

  • Received August 9, 2023
  • Accepted November 17, 2023
  • First published December 10, 2023.
Online issue publication 
December 10, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.